Skip to main content
CING
NASDAQ Life Sciences

Cingulate Inc. Expands At-The-Market Offering by $8.84 Million, Signaling Significant Dilution

KI-Analyse von Wiseek
Stimmung info
Negativ
Wichtigkeit info
8
Preis
$5.44
Marktkapitalisierung
$40.508M
52W Tief
$3.2
52W Hoch
$6.01
Market data snapshot near publication time

summarizeZusammenfassung

Cingulate Inc. has significantly expanded its At-The-Market (ATM) offering program, increasing the maximum aggregate offering price by $8.4 million to a total of $31.9 million. Concurrently, the company filed a prospectus supplement for an additional $8.84 million under this expanded program. This substantial capital raise, representing a significant portion of the company's market capitalization, indicates a strong need for funding and will result in considerable dilution for existing shareholders. Investors should monitor the pace and pricing of these sales as they occur, as continuous share issuance can create an overhang on the stock price.


check_boxSchlusselereignisse

  • ATM Program Expansion

    Cingulate Inc. increased the maximum aggregate offering price of its At-The-Market (ATM) offering agreement from $23,536,658 to $31,936,658.

  • New Offering Tranche

    The company filed a prospectus supplement for an additional $8,840,000 of common stock under the expanded ATM program.

  • Significant Dilution Potential

    This capital raise represents a substantial portion of the company's current market capitalization, indicating significant potential dilution for existing shareholders.


auto_awesomeAnalyse

Cingulate Inc. has significantly expanded its At-The-Market (ATM) offering program, increasing the maximum aggregate offering price by $8.4 million to a total of $31.9 million. Concurrently, the company filed a prospectus supplement for an additional $8.84 million under this expanded program. This substantial capital raise, representing a significant portion of the company's market capitalization, indicates a strong need for funding and will result in considerable dilution for existing shareholders. Investors should monitor the pace and pricing of these sales as they occur, as continuous share issuance can create an overhang on the stock price.

Zum Zeitpunkt dieser Einreichung wurde CING bei 5,44 $ gehandelt an der NASDAQ im Sektor Life Sciences, bei einer Marktkapitalisierung von rund 40,5 Mio. $. Die 52-Wochen-Handelsspanne lag zwischen 3,20 $ und 6,01 $. Diese Einreichung wurde mit negativer Marktstimmung und einem Wichtigkeitsscore von 8 von 10 bewertet.

descriptionHaupt-SEC-Einreichung ansehen

show_chartPreisdiagramm

Diesen Artikel teilen

Copied!

feed CING - Neueste Einblicke

CING
Apr 28, 2026, 4:24 PM EDT
Filing Type: 424B3
Importance Score:
8
CING
Apr 14, 2026, 5:26 PM EDT
Filing Type: S-3
Importance Score:
8
CING
Mar 27, 2026, 4:01 PM EDT
Filing Type: 424B3
Importance Score:
8
CING
Mar 26, 2026, 4:24 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
8
CING
Mar 24, 2026, 5:14 PM EDT
Filing Type: 8-K
Importance Score:
9
CING
Mar 24, 2026, 5:13 PM EDT
Filing Type: 424B3
Importance Score:
9
CING
Mar 19, 2026, 6:00 PM EDT
Filing Type: S-3
Importance Score:
8
CING
Mar 18, 2026, 4:30 PM EDT
Filing Type: DEFA14A
Importance Score:
8
CING
Mar 18, 2026, 8:13 AM EDT
Filing Type: 10-K
Importance Score:
9
CING
Mar 18, 2026, 8:10 AM EDT
Filing Type: 8-K
Importance Score:
9